ID: MRFR/LS/4149-HCR | 90 Pages | Author: Kinjoll Dey | November 2023
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Metagenomic sequencing Market, by Technology
6.1 Introduction
6.2 Sequencing
6.2.1 Market Estimates & Forecast, 2020 – 2023
6.3 Bioinformatics
6.3.1 Market Estimates & Forecast, 2020 – 2023
6.4 Others
Chapter 7. Global Metagenomic sequencing Market, by Application
7.1 Introduction
7.2 Infectious disease diagnosis
7.2.1 Market Estimates & Forecast, 2023-2032
7.3 Environmental remediation
7.3.1 Market Estimates & Forecast, 2023-2032
7.4 Gut microbe characterization
7.4.1 Market Estimates & Forecast, 2023-2032
7.5 Biotechnology
7.5.1 Market Estimates & Forecast, 2023-2032
7.6 Biofuel
7.6.1 Market Estimates & Forecast, 2023-2032
7.7 Ecology
7.7.1 Market Estimates & Forecast, 2023-2032
7.8 Agriculture
7.8.1 Market Estimates & Forecast, 2023-2032
7.9 Others
Chapter 8. Global Metagenomic sequencing Market, by End User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Estimates & Forecast, 2023-2032
8.3 Ambulatory Surgical Centers
8.3.1 Market Estimates & Forecast, 2023-2032
8.4 Specialized Clinics
8.4.1 Market Estimates & Forecast, 2023-2032
8.5 Others
Chapter. 9 Global Metagenomic sequencing Market, by Region
9.1 Introduction
9.2 Americas
9.2.1 North America
9.2.1.1 U.S.
9.2.1.1 Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 U.K
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia Pacific
9.5 The Middle East & Africa
9.5.1 United Arab Emirates
9.5.2 Saudi Arabia
9.5.3 Rest of the Middle East & Africa
Chapter 10 Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
10.3.1 Key Developments
Chapter 11 Company Profiles
11.1 GATC Biotech AG
11.1.1 Company Overview
11.1.2 Application Overview
11.1.3 Financials
11.1.4 SWOT Analysis
11.2 Enterome Bioscience
11.2.1 Company Overview
11.2.2 Application Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Illumina Inc.
11.3.1 Company Overview
11.3.2 Application Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Quest Diagnostics
11.4.1 Company Overview
11.4.2 Applications/Business Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 F Hoffman-La Roche Ltd.
11.5.1 Company Overview
11.5.2 Application Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.6 Thermo Fisher Scientific Inc.
11.6.1 Company Overview
11.6.2 Application Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.7 CLC Bio
11.7.1 Overview
11.7.2 Application Overview
11.7.3 Financials
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Agilent Technologies Inc.
11.8.1 Company Overview
11.8.2 Applications/Business Segment Overview
11.8.3 Financial Overview
11.8.4 Key Development
11.8.5 SWOT Analysis
11.9 Macrogen Inc.
11.9.1 Company Overview
11.9.2 Application Overview
11.9.3 Financial overview
11.9.4 Key Developments
11.10 Helicos BioSciences
11.10.1 Company Overview
11.10.2 Application Overview
11.10.3 Financial overview
11.10.4 Key Developments
11.11 Others
Chapter 12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs of the Market
12.2 Key Companies to Watch
12.3 Prediction of Pharmaceutical industry
Chapter 13 Appendix
LIST OF TABLES
Table 1 Metagenomic sequencing Industry Synopsis, 2023-2032
Table 2 Metagenomic sequencing Market Estimates and Forecast, 2023-2032, (USD Million)
Table 3 Metagenomic sequencing Market by Region, 2023-2032, (USD Million)
Table 4 Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 5 Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 6 Metagenomic sequencing Market by End Users, 2023-2032, (USD Million)
Table 7 North America Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 8 North America Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 9 North America Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 10 US Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 11 US Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 12 US Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 13 Canada Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 14 Canada Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 15 Canada Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 16 South America Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 17 South America Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 18 South America Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 19 Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 20 Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 21 Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 22 Western Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 23 Western Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 24 Western Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 25 Eastern Europe Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 26 Eastern Europe Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 27 Eastern Europe Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 28 Asia Pacific Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 29 Asia Pacific Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 30 Asia Pacific Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
Table 31 The Middle East & Africa Metagenomic sequencing Market by Technology, 2023-2032, (USD Million)
Table 32 The Middle East & Africa Metagenomic sequencing Market by Applications, 2023-2032, (USD Million)
Table 33 The Middle East & Africa Metagenomic sequencing Market by End User, 2023-2032, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Metagenomic sequencing Market
Figure 3 Segmentation Market Dynamics for Metagenomic sequencing Market
Figure 4 Global Metagenomic sequencing Market Share, by Technology 2020
Figure 5 Global Metagenomic sequencing Market Share, by Application2020
Figure 6 Global Metagenomic sequencing Market Share, by End Users, 2020
Figure 7 Global Metagenomic sequencing Market Share, by Region, 2020
Figure 8 North America Metagenomic sequencing Market Share, by Country, 2020
Figure 9 Europe Metagenomic sequencing Market Share, by Country, 2020
Figure 10 Asia Pacific Metagenomic sequencing Market Share, by Country, 2020
Figure 11 The Middle East & Africa Metagenomic sequencing Market Share, by Country, 2020
Figure 12 Global Metagenomic sequencing Market: Company Share Analysis, 2020 (%)
Figure 13 GATC Biotech AG: Key Financials
Figure 14 GATC Biotech AG: Segmental Revenue
Figure 15 GATC Biotech AG: Geographical Revenue
Figure 16 Enterome Bioscience: Key Financials
Figure 17 Enterome Bioscience: Segmental Revenue
Figure 18 Enterome Bioscience: Geographical Revenue
Figure 19 Illumina Inc.: Key Financials
Figure 20 Illumina Inc.: Segmental Revenue
Figure 22 Illumina Inc.: Geographical Revenue
Figure 23 Quest Diagnostics: Key Financials
Figure 24 Quest Diagnostics: Segmental Revenue
Figure 25 Quest Diagnostics: Geographical Revenue
Figure 27 F Hoffman-La Roche Ltd.: Key Financials
Figure 28 F Hoffman-La Roche Ltd.: Segmental Revenue
Figure 29 F Hoffman-La Roche Ltd.: Geographical Revenue
Figure 30 Thermo Fisher Scientific Inc.: Key Financials
Figure 32 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 33 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 33 Tornier N.V.: Key Financials
Figure 34 Tornier N.V.: Segmental Revenue
Figure 35 Tornier N.V.: Geographical Revenue
Figure 36 Össur: Key Financials
Figure 37 Össur: Segmental Revenue
Figure 38 Össur: Geographical Revenue
Figure 39 Acumed, LLC: Key Financials
Figure 40 Acumed, LLC: Segmental Revenue
Figure 41 Acumed, LLC: Geographical Revenue
Metagenomic Sequencing Market Segmentation
Metagenomic Sequencing Product & Service Outlook (USD Billion, 2018-2032)
Reagents and Consumables
Instruments
Services
Metagenomic Sequencing Technology Outlook (USD Billion, 2018-2032)
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Metagenomic Sequencing Regional Outlook (USD Billion, 2018-2032)
North America Outlook (USD Billion, 2018-2032)
North America Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
North America Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
US Outlook (USD Billion, 2018-2032)
US Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
US Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
CANADA Outlook (USD Billion, 2018-2032)
CANADA Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
CANADA Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Europe Outlook (USD Billion, 2018-2032)
Europe Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Europe Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Germany Outlook (USD Billion, 2018-2032)
Germany Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Germany Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
France Outlook (USD Billion, 2018-2032)
France Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
France Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
UK Outlook (USD Billion, 2018-2032)
UK Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
UK Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
ITALY Outlook (USD Billion, 2018-2032)
ITALY Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
ITALY Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
SPAIN Outlook (USD Billion, 2018-2032)
Spain Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Spain Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Rest Of Europe Outlook (USD Billion, 2018-2032)
Rest Of Europe Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
REST OF EUROPE Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Asia-Pacific Outlook (USD Billion, 2018-2032)
Asia-Pacific Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Asia-Pacific Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
China Outlook (USD Billion, 2018-2032)
China Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
China Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Japan Outlook (USD Billion, 2018-2032)
Japan Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Japan Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
India Outlook (USD Billion, 2018-2032)
India Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
India Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Australia Outlook (USD Billion, 2018-2032)
Australia Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Australia Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
Rest of Asia-Pacific Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Rest of Asia-Pacific Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Rest of the World Outlook (USD Billion, 2018-2032)
Rest of the World Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Rest of the World Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Middle East Outlook (USD Billion, 2018-2032)
Middle East Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Middle East Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Africa Outlook (USD Billion, 2018-2032)
Africa Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Africa Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic
Latin America Outlook (USD Billion, 2018-2032)
Latin America Metagenomic Sequencing by Product & Service
Reagents and Consumables
Instruments
Services
Latin America Metagenomic Sequencing by Technology
Shotgun Metagenomic Sequencing
16s rRNA Sequencing
Whole Genome Sequencing and De Novo Assembly
Metatranscriptomic